Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes.
作者信息
Alebouyeh Masoud, Yadegar Abbas, Farzi Nastaran, Miri Marzyieh, Zojaji Homayoon, Gharibi Somayeh, Fazeli Zeinab, Ebrahimi Daryani Naser, Asadzadeh Aghdaei Hamid, Zali Mohammad Reza
机构信息
Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
出版信息
Gastroenterol Hepatol Bed Bench. 2015 Spring;8(Suppl 1):S1-5.
Abstract
摘要
相似文献
1
Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes.
Gastroenterol Hepatol Bed Bench. 2015 Spring;8(Suppl 1):S1-5.
2
Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysis.
Microb Pathog. 2022 Sep;170:105720. doi: 10.1016/j.micpath.2022.105720. Epub 2022 Aug 12.
3
Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis.
Ann Clin Microbiol Antimicrob. 2022 May 20;21(1):19. doi: 10.1186/s12941-022-00509-3.
4
Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept.
Helicobacter. 2020 Feb;25(1):e12670. doi: 10.1111/hel.12670. Epub 2019 Nov 8.
5
Characteristics of Heteroresistance in Gastric Biopsies and Its Clinical Relevance.
Front Cell Infect Microbiol. 2022 Feb 4;11:819506. doi: 10.3389/fcimb.2021.819506. eCollection 2021.
6
Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children.
Helicobacter. 2023 Oct;28(5):e13006. doi: 10.1111/hel.13006. Epub 2023 Jul 4.
7
and Its Antibiotic Heteroresistance: A Neglected Issue in Published Guidelines.
Front Microbiol. 2019 Aug 13;10:1796. doi: 10.3389/fmicb.2019.01796. eCollection 2019.
8
Heteroresistance of Helicobacter pylori from the same patient prior to antibiotic treatment.
Infect Genet Evol. 2014 Apr;23:196-202. doi: 10.1016/j.meegid.2014.02.009. Epub 2014 Feb 24.
9
Prevalence of heteroresistant Helicobacter pylori and treatment follow-up in patients in Ilam, Iran.
GMS Hyg Infect Control. 2024 May 17;19:Doc24. doi: 10.3205/dgkh000479. eCollection 2024.
10
Droplet Digital PCR-Based Detection of Clarithromycin Resistance in Helicobacter pylori Isolates Reveals Frequent Heteroresistance.
J Clin Microbiol. 2018 Aug 27;56(9). doi: 10.1128/JCM.00019-18. Print 2018 Sep.
引用本文的文献
1
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):613-629. doi: 10.1038/s41575-021-00449-x. Epub 2021 May 17.
2
approach towards the identification of potential inhibitors from Roxb against : ADMET screening and molecular docking studies.
Bioimpacts. 2021;11(2):119-127. doi: 10.34172/bi.2021.19. Epub 2020 Mar 24.
3
Using next-generation sequencing to analyze Helicobacter pylori clones with different levofloxacin resistances from a patient with eradication failure.
Medicine (Baltimore). 2020 Aug 7;99(32):e20761. doi: 10.1097/MD.0000000000020761.
4
Next-Generation Sequencing of the Whole Bacterial Genome for Tracking Molecular Insight into the Broad-Spectrum Antimicrobial Resistance of Clinical Isolates from the Democratic Republic of Congo.
Microorganisms. 2020 Jun 11;8(6):887. doi: 10.3390/microorganisms8060887.
5
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori.
BMC Microbiol. 2019 Aug 5;19(1):176. doi: 10.1186/s12866-019-1558-8.
6
Characterization of clarithromycin heteroresistance among Helicobacter pylori strains isolated from the antrum and corpus of the stomach.
Folia Microbiol (Praha). 2019 Mar;64(2):143-151. doi: 10.1007/s12223-018-0637-9. Epub 2018 Aug 10.
7
Management of multi-drug resistant infection by supplementary, complementary and alternative medicine; a review.
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S8-S14.
8
Seven-day genotypic resistance-guided triple eradication therapy can be highly effective.
Ann Gastroenterol. 2018 Mar-Apr;31(2):198-204. doi: 10.20524/aog.2017.0219. Epub 2017 Nov 30.
本文引用的文献
1
Role of age in association between gastric cancer and Helicobacter pylori eradication in cases with intestinal metaplasia and dysplasia.
Gastric Cancer. 2016 Jul;19(3):1023. doi: 10.1007/s10120-015-0498-8. Epub 2015 Apr 17.
2
Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.
World J Gastroenterol. 2015 Apr 7;21(13):3936-43. doi: 10.3748/wjg.v21.i13.3936.
3
Is There Any Difference in the Eradication Rate of Helicobacter pylori Infection According to the Endoscopic Stage of Peptic Ulcer Disease?
Helicobacter. 2015 Dec;20(6):424-30. doi: 10.1111/hel.12221. Epub 2015 Mar 5.
4
Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Asian Pac J Cancer Prev. 2015;16(4):1571-4. doi: 10.7314/apjcp.2015.16.4.1571.
5
Genotype Diversity and Quasispecies Development of Helicobacter pylori in a Single Host.
Jpn J Infect Dis. 2015;68(3):176-80. doi: 10.7883/yoken.JJID.2014.165.
6
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.
Gastroenterology. 2015 Apr;148(4):719-31.e3. doi: 10.1053/j.gastro.2015.01.040. Epub 2015 Feb 2.
7
Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection.
World J Gastroenterol. 2014 Nov 21;20(43):16245-51. doi: 10.3748/wjg.v20.i43.16245.
8
Prevalence of multiple drug-resistant Helicobacter pylori strains among patients with different gastric disorders in Iran.
Microb Drug Resist. 2015 Feb;21(1):105-10. doi: 10.1089/mdr.2014.0081. Epub 2014 Oct 10.
9
Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pylori.
Helicobacter. 2014 Dec;19(6):455-61. doi: 10.1111/hel.12147. Epub 2014 Sep 18.
10
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Cancer Lett. 2014 Dec 1;355(1):106-12. doi: 10.1016/j.canlet.2014.09.010. Epub 2014 Sep 11.
Zotero 插件